Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Debt / NOTE 2.000% 8/1
-
Market price (% of par)
-
66.4%
-
Total 13F principal
-
$344,442,500
-
Principal change
-
+$3,975,000
-
Total reported market value
-
$228,110,379
-
Number of holders
-
30
-
Value change
-
+$1,251,721
-
Number of buys
-
10
-
Number of sells
-
12
Institutional Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q4 2015
As of 31 Dec 2015,
AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 was held by
30 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$344,442,500
in principal (par value) of the bond.
The largest 10 bondholders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, Allianz Asset Management AG, BAKER BROS. ADVISORS LP, UBS OCONNOR LLC, WOLVERINE ASSET MANAGEMENT LLC, ZAZOVE ASSOCIATES LLC, Tekla Capital Management LLC, and Telemetry Investments, L.L.C..
This page lists
30
institutional bondholders reporting positions
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.